Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’s ...
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA salesMore than 2,000 unique patient prescriptions and ...
Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases through precise, innovative ...
As a recognized leader in AI strategy and enterprise transformation, Cognizant brings credibility and clarity to this evolving space. It has been named a Leader and Star Performer by Everest Group in ...
On Wednesday, Oct. 29, the Food and Drug Administration (FDA) issued draft guidance proposing to update its biosimilar review framework. Under the ...
Fairfield University's Charles Dolan School of Business. Photo courtesy of Fairfield University FAIRFIELD — Business professors from Fairfield University’s Dolan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback